Neoadjuvant therapy with ipilimumab and nivolumab for stage III malignant melanoma - a case report

被引：0
|
作者：
Hansen, I. [1 ]
Heidrich, I. [1 ]
Belz, S. [1 ]
Noebel, C. [1 ]
Geidel, G. [1 ]
Hildebrandt, L. [1 ]
Schneider, S. W. [1 ]
Gebhardt, C. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Klin Dermatol & Venerol, Hamburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP096
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [21] Nivolumab and ipilimumab therapy for advanced melanoma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2013, 14 (08): : E298 - E298
  • [22] Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
    Irene L. M. Reijers
    Alexander M. Menzies
    Alexander C. J. van Akkooi
    Judith M. Versluis
    Noëlle M. J. van den Heuvel
    Robyn P. M. Saw
    Thomas E. Pennington
    Ellen Kapiteijn
    Astrid A. M. van der Veldt
    Karijn P. M. Suijkerbuijk
    Geke A. P. Hospers
    Elisa A. Rozeman
    Willem M. C. Klop
    Winan J. van Houdt
    Karolina Sikorska
    Jos A. van der Hage
    Dirk J. Grünhagen
    Michel W. Wouters
    Arjen J. Witkamp
    Charlotte L. Zuur
    Judith M. Lijnsvelt
    Alejandro Torres Acosta
    Lindsay G. Grijpink-Ongering
    Maria Gonzalez
    Katarzyna Jóźwiak
    Carolien Bierman
    Kerwin F. Shannon
    Sydney Ch’ng
    Andrew J. Colebatch
    Andrew J. Spillane
    John B. A. G. Haanen
    Robert V. Rawson
    Bart A. van de Wiel
    Lonneke V. van de Poll-Franse
    Richard A. Scolyer
    Annelies H. Boekhout
    Georgina V. Long
    Christian U. Blank
    Nature Medicine, 2022, 28 : 1178 - 1188
  • [23] Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
    Reijers, Irene L. M.
    Menzies, Alexander M.
    van Akkooi, Alexander C. J.
    Versluis, Judith M.
    van den Heuvel, Noelle M. J.
    Saw, Robyn P. M.
    Pennington, Thomas E.
    Kapiteijn, Ellen
    van der Veldt, Astrid A. M.
    Suijkerbuijk, Karijn P. M.
    Hospers, Geke A. P.
    Rozeman, Elisa A.
    Klop, Willem M. C.
    van Houdt, Winan J.
    Sikorska, Karolina
    van der Hage, Jos A.
    Grunhagen, Dirk J.
    Wouters, Michel W.
    Witkamp, Arjen J.
    Zuur, Charlotte L.
    Lijnsvelt, Judith M.
    Torres Acosta, Alejandro
    Grijpink-Ongering, Lindsay G.
    Gonzalez, Maria
    Jozwiak, Katarzyna
    Bierman, Carolien
    Shannon, Kerwin F.
    Ch'ng, Sydney
    Colebatch, Andrew J.
    Spillane, Andrew J.
    Haanen, John B. A. G.
    Rawson, Robert V.
    van de Wiel, Bart A.
    van de Poll-franse, Lonneke V.
    Scolyer, Richard A.
    Boekhout, Annelies H.
    Long, Georgina V.
    Blank, Christian U.
    NATURE MEDICINE, 2022, 28 (06) : 1178 - +
  • [24] Necrotizing leukocytoclastic Vasculitis under Therapy with Ipilimumab and Nivolumab in a Patient with malignant Melanoma
    Stege, H.
    Bradfisch, F.
    Henning, B.
    Weidenthaler-Barth, B.
    Saloga, J.
    Grabbe, S.
    Louqai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 72 - 72
  • [25] Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma
    Sakaguchi, Yuri
    Komori, Takaya
    Aoki, Megumi
    Otsuka, Atsushi
    Kabashima, Kenji
    Matsushita, Shigeto
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 1 - 2
  • [26] Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
    Marin A. McDonald
    Parag Sanghvi
    Julie Bykowski
    Gregory A. Daniels
    BMC Cancer, 18
  • [27] Milestones in the Treatment of malignant Melanoma Nivolumab in the Adjuvant and as a Combination Therapy with Ipilimumab in Patients with advanced Melanoma
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (7-8) : 414 - 415
  • [28] Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial
    Lucas, M. W.
    Menzies, A. M.
    Lopez-Yurda, M.
    Scolyer, R. A.
    van de Wiel, B.
    Saw, R. P. M.
    Van Houdt, W.
    Maher, N.
    Acosta, A. Torres
    Boers-Sonderen, M.
    Hospers, G.
    Carlino, M. S.
    de Groot, J. W.
    Kapiteijn, E.
    Suijkerbuijk, K.
    Rutkowski, P.
    Sandhu, S. K.
    Van der Veldt, A. A. M.
    Long, G. V.
    Blank, C. U.
    ANNALS OF ONCOLOGY, 2024, 35 : 1233 - 1234
  • [29] Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
    McDonald, Marin A.
    Sanghvi, Parag
    Bykowski, Julie
    Daniels, Gregory A.
    BMC CANCER, 2018, 18
  • [30] Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab
    Krueger, Oskar
    Eisenburger, Robin
    Tasdogan, Alpaslan
    Zimmer, Lisa
    Livingstone, Elisabeth
    Hadaschik, Eva
    Theurer, Sarah
    Brodin, Berthold
    Schadendorf, Dirk
    Ugurel, Selma
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345